An infant with γ-globulin-induced hypersensitivity syndrome who developed Evans' syndrome after a second γ-globulin treatment

Modern Rheumatology

Volumn 14, Issue 4, 2004, Pages 314-319

  Miyamae, Takako ^a   Kurosawa, Rumiko ^a   Mori, Masaaki ^a   Aihara, Yukoh ^a   Aihara, Michiko ^a   Yokota, Shumpei ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

globulin; Autoimmune hemolytic anemia and thrombocytopenia; Hypersensitivity syndrome (DIHS); Intrahepatic cholestasis; Kawasaki disease

Indexed keywords

ACETYLSALICYLIC ACID; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; COLD AGGLUTININ; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; PREDNISOLONE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE HEMOLYTIC ANEMIA; BONE MARROW EXAMINATION; CASE REPORT; CHILD; CLINICAL FEATURE; COOMBS TEST; CYTOKINE PRODUCTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DRUG INDUCED DISEASE; EOSINOPHILIA; ERYTHROCYTE SEDIMENTATION RATE; FACE EDEMA; FEMALE; HEPATOSPLENOMEGALY; HOSPITAL ADMISSION; HUMAN; HUMAN HERPESVIRUS 6; HYPERBILIRUBINEMIA; HYPERSENSITIVITY; INTRAHEPATIC CHOLESTASIS; JAUNDICE; LABORATORY TEST; LEUKOPENIA; LIVER BIOPSY; LYMPHADENOPATHY; LYMPHOCYTOSIS; MUCOCUTANEOUS LYMPH NODE SYNDROME; PHYSICAL EXAMINATION; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEINURIA; REAL TIME POLYMERASE CHAIN REACTION; RECURRENT DISEASE; SEROLOGY; THROMBOCYTOPENIA; TREATMENT OUTCOME; VIRUS GENOME; VIRUS REACTIVATION;

EID: 20444406114     PISSN: 14397595     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10165-004-0316-3     Document Type: Article

References (23)

1. Callot V, Roujeau JC, Bagot M, Wechsler J, Chosidow O, Souteyrand P. Drug-induced pseudolymphoma and hypersensitivity syndrome. Arch Dermatol 1996;132:1315-21.
2. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994;331:1272-85.
3. Shear NH, Spielberg SP. Antiepileptic hypersensitivity syndrome. In vitro assessment of risk. J Clin Invest 1988;82:1826-32.
4. Descamps V, Valance A, Edlinger C, Fillet AM, Grossin M, Lebrun-Vignes B, et al. Association of human herpes virus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch Dermatol 2001;137:301-4.
5. Suzuki Y, Inagi R, Aono T, Yamanishi K, Shiohara T. Human herpes virus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome. Arch Dermatol 1998;134:1108-12.
6. Evans RS, Duane RT. Acquired hemolytic anemia. I. The relation of erythrocyte antibody production to activity of the disease. II. The significance of thrombocytopenia and leukopenia. Blood 1949;4:1196-213.
7. Wang WC. Evans syndrome in childhood: Pathophysiology, clinical course, and treatment. Am J Pediatr Hematol Oncol 1988; 10:330-8.
8. Bennett JC, Plum F. Cecil textbook of medicine. 20th ed. New York: WB Saunders; 1996.
9. Japan Kawasaki Disease Research Committee. Diagnostic guidelines of Kawasaki disease. 4th rev. ed. Tokyo; 1984.
10. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Clinical observation of 50 cases. Jpn J Allergy 1967;16:178-222.
11. Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 1991;324:1633-9.
12. Sato N, Sugimura T, Akagi T, Yamakawa R, Hashino K, Eto G, et al. Selective high-dose gamma-globulin treatment in Kawasaki disease: assessment of clinical aspects and cost effectiveness. Pediatr Int 1999;41:1-7.
13. Yanagawa H, Nakamura Y, Yashiro M, Oki I, Hirata S, Zhang T, et al. Incidence survey of Kawasaki disease in 1997 and 1998 in Japan. Pediatrics 2001;107:576.
14. Brox AG, Cournoyer D, Sternbach M, Spurl G. Hemolytic anemia following intravenous gammma globulin administration. Am J Med 1987;82:633-5.
15. Comenzo RL, Malachowski ME, Meissner HC, Hulton DR, Berkman EM. Immune hemolysis, disseminated intravascular coagulation, and serum sickness after large doses of imunne globlin given intravenously for Kawasaki disease. J Pediatr 1992;120:926-8.
16. Descamps V, Bourscarat F, Laglenne S, Aslangul E, Veber B, Descamps D, et al. Human herpes virus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome. Br J Dermatol 1997;137:605-8.
17. Carroll MC, Yueng-Yue KA, Esterly NB, Drolet BA. Drug-induced hypersensitivity syndrome in pediatric patients. Pediatrics 2001;108:485-93.
18. Mauri-Hellweg D, Bettens F, Mauri D, Hunziker T, Pichler WJ. Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenitoin, and carbamazepine. J Immunol 1995;155:462-72.
19. Gupta N, Ahmed I, Nissel-Horowitz S, Patel D, Mehrotra B. Intravenous gamma globulin-associated acute renal failure. Am J Hematol 2001;66:151-2.
20. Kato E, Shindo S, Eto Y, Hashimoto N, Yamamoto M, Sakata Y, et al. Administration of immune globulin associated with aseptic meningitis. JAMA 1988;259:3269-71.
21. Tohyama M, Yahata Y, Yasukawa M, Inagi R, Urano Y, Yamanishi K, et al. Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpes virus 6. Arch Dermatol 1998;134:1113-7.
22. Tohyama M, Hashimoto K. Hypersensitivity syndrome (in Japanese). Hifubyo-shinryo 2000;22:126-9.
23. Hillyer CD, Schwenn MR, Fulton DR, Meissner HC, Berkman EM. Autoimmune hemolytic anemia in Kawasaki disease. Transfusion 1990;30:738-40.